Xtant Medical Holdings (XTNT) Revenue (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Revenue data on file, last reported at $33.3 million in Q3 2025.

• On a quarterly basis, Revenue rose 19.04% year-over-year to $33.3 million in Q3 2025; TTM through Sep 2025 was $133.1 million, a 16.88% increase from a year earlier, with the FY2024 full-year figure at $117.3 million, up 28.44% from the prior year.
• Revenue for Q3 2025 stood at $33.3 million, down from $35.4 million in the prior quarter.
• Over the last five years, Revenue for XTNT reached as high as $35.4 million in Q2 2025 and fell as low as $12.5 million in Q1 2021.
• Historically, Revenue has averaged $22.3 million across 5 years, with a median of $20.2 million in 2023.
• Across the five-year window, Revenue decreased 14.88% in 2021 and jumped 84.07% in 2023, its largest moves.
• Year by year, Revenue stood at $14.1 million in 2021, then increased by 8.53% to $15.3 million in 2022, then surged by 84.07% to $28.1 million in 2023, then rose by 12.11% to $31.5 million in 2024, then increased by 5.53% to $33.3 million in 2025.
• Per Business Quant data, the three most recent Revenue figures were $33.3 million in Q3 2025, $35.4 million in Q2 2025, and $32.9 million in Q1 2025.